Hjem › Myeloproliferative neoplasmer
Myeloproliferative neoplasmer kliniske forsøg rekrutterer i USA
50 studier for Myeloproliferative neoplasmer rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Chicago, IL9 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Birmingham, AL8 studier
- Atlanta, GA8 studier
- Cleveland, OH8 studier
- Salt Lake City, UT8 studier
- Tampa, FL8 studier
- St. Louis, MO8 studier
- Columbus, OH8 studier
- Philadelphia, PA8 studier
- Portland, OR8 studier
- Los Angeles, CA7 studier
- Baltimore, MD7 studier
- Mountain View, CA7 studier
- Winston-Salem, NC7 studier
- Kansas City, MO7 studier
- Nashville, TN6 studier
- Irvine, CA6 studier
- Charlotte, NC6 studier
- Ann Arbor, MI6 studier
- Jacksonville, FL6 studier
- Phoenix, AZ6 studier
- Sacramento, CA5 studier
- Washington, DC5 studier
- Omaha, NE5 studier
- Charlottesville, VA5 studier
- San Francisco, CA5 studier
- Edison, NJ5 studier
- Rochester, MN5 studier
- Pittsburgh, PA5 studier
- Minneapolis, MN5 studier
- The Bronx, NY4 studier
- New Haven, CT4 studier
Efter delstat
- Alabama8 studier
- Arizona8 studier
- Arkansas4 studier
- Californien17 studier
- Colorado6 studier
- Connecticut5 studier
- Florida13 studier
- Georgia10 studier
- Hawaii3 studier
- Idaho4 studier
- Illinois9 studier
- Indiana4 studier
- Iowa4 studier
- Kansas6 studier
- Kentucky3 studier
- Louisiana4 studier
- Maine4 studier
- Maryland8 studier
- Massachusetts15 studier
- Michigan8 studier
- Minnesota8 studier
- Mississippi4 studier
- Missouri8 studier
- Montana3 studier
- Nebraska5 studier
- Nevada3 studier
- New Jersey5 studier
- New Mexico4 studier
- New York15 studier
- North Carolina13 studier
- Ohio11 studier
- Oklahoma5 studier
- Oregon8 studier
- Pennsylvania10 studier
- Rhode Island4 studier
- South Carolina5 studier
- Tennessee8 studier
- Texas18 studier
- Utah8 studier
- Vermont3 studier
- Virginia6 studier
- Washington9 studier
- Wisconsin10 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
RekruttererFase 1/2
Alder 12 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06303193A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07469891Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT06131801A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06661915MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT05320198Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
Alder 18 til 59 · Alle køn · Opdateret 22. sep. 2026 · NCT05554406Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
RekruttererFase 1
Alder 1 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT03630991Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT04282187(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT03471260Cord Blood Transplant in Adults With Blood Cancers
RekruttererFase 2
Alder 21 til 65 · Alle køn · Opdateret 11. sep. 2026 · NCT05884333Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT06291987Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT06523556CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT04493164Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Rekrutterer
Alder 19 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04898790Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07565220A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07008118Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT07249840A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07020533Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT07441694Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RekruttererFase 2
6 Months – 65 Years · Alle køn · Opdateret 22. jul. 2026 · NCT06013423Evaluation of the Pathobiology of CALR-mutated MPN Cells
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT06480591Allo HSCT Using RIC and PTCy for Hematological Diseases
RekruttererFase 2
Op til 75 år · Alle køn · Opdateret 6. jul. 2026 · NCT05805605Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.